21 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent thereof
8-K
EX-1.1
VERV
Verve Therapeutics Inc
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
a Material Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent
S-3
EX-1.2
VERV
Verve Therapeutics Inc
1 Jul 22
Shelf registration
4:36pm
material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent thereof, in any form or amount, including petroleum
S-1/A
EX-1.1
VERV
Verve Therapeutics Inc
14 Jun 21
IPO registration (amended)
6:15am
or in the aggregate, reasonably be expected to have a Material Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste
10-Q
4owlmdfz7et8zehh3lu4
12 Aug 21
Quarterly report
8:53am
10-K
xn715gf
14 Mar 22
Annual report
7:04am
DRS
c3058egj4
16 Apr 21
Draft registration statement
12:00am
S-1/A
g7wb83jju5mvok vn3
14 Jun 21
IPO registration (amended)
6:15am
424B4
9ift4f2trqay1bfybxxr
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1
p8rv5rizntmq6woxp25
28 May 21
IPO registration
4:04pm